Back to Results
First PageMeta Content
Organofluorides / Angiology / Orphan drugs / Vascular endothelial growth factor / Riociguat / Sorafenib / Alpharadin / Bayer / Angiogenesis / Medicine / Chemistry / Organic chemistry


Bayer: Innovation & Sustainability 2011 Our Mission Bayer: Science For A Better Life
Add to Reading List

Document Date: 2011-06-23 11:34:37


Open Document

File Size: 2,04 MB

Share Result on Facebook

City

San Francisco / Cologne / /

Company

AMD / Bayer / Food Chain Partnership / /

Country

United States / /

Currency

EUR / /

Event

FDA Phase / /

Facility

GDD Innovation Center / Pharmaceuticals pipeline / EcoCommercial Building / /

IndustryTerm

resource friendly products / Blood glucose monitoring systems / devices enabling imaging / food / energy / animal products / /

MedicalCondition

heart failure / diseases / Neglected diseases / Uterine Fibroids / Endometriosis / Thrombosis /Acute coronary syndrome / Pulmonary hypertension / /

MedicalTreatment

Contraception / Eye Contraception / /

NaturalFeature

ED BAY / /

Organization

Pharmaceuticals Division / /

Position

driver / Major / General / /

Product

Cipro / Nexavar / CA9-ADC / /

Technology

Diagnostic Imaging / ADC / Drug Discovery / apoptosis / MRI / /

SocialTag